These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32926604)

  • 21. Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive-Compulsive and Impulsive Features in Adults with Binge Eating Disorder.
    McElroy SL; Mitchell JE; Wilfley D; Gasior M; Ferreira-Cornwell MC; McKay M; Wang J; Whitaker T; Hudson JI
    Eur Eat Disord Rev; 2016 May; 24(3):223-31. PubMed ID: 26621156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Characteristics and Treatment Response to Lisdexamfetamine Dimesylate Versus Placebo in Adults With Binge Eating Disorder: Analysis by Gender and Age.
    Kornstein SG; Bliss C; Kando J; Madhoo M
    J Clin Psychiatry; 2019 Feb; 80(2):. PubMed ID: 30817099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.
    Grilo CM; Lydecker JA; Morgan PT; Gueorguieva R
    Clin Ther; 2021 Jan; 43(1):112-122.e1. PubMed ID: 33218742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder.
    Yee K; Serrano D; Kando J; McElroy SL
    Qual Life Res; 2019 Dec; 28(12):3385-3394. PubMed ID: 31473907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa.
    Dalai SS; Adler S; Najarian T; Safer DL
    Contemp Clin Trials; 2018 Jan; 64():173-178. PubMed ID: 29038069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.
    McElroy SL; Kotwal R; Hudson JI; Nelson EB; Keck PE
    J Clin Psychiatry; 2004 Jan; 65(1):50-6. PubMed ID: 14744168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
    Weisler RH; Greenbaum M; Arnold V; Yu M; Yan B; Jaffee M; Robertson B
    CNS Drugs; 2017 Aug; 31(8):685-697. PubMed ID: 28712074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Armodafinil in binge eating disorder: a randomized, placebo-controlled trial.
    McElroy SL; Guerdjikova AI; Mori N; Blom TJ; Williams S; Casuto LS; Keck PE
    Int Clin Psychopharmacol; 2015 Jul; 30(4):209-15. PubMed ID: 26011779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, placebo-controlled crossover trial of phentermine-topiramate ER in patients with binge-eating disorder and bulimia nervosa.
    Safer DL; Adler S; Dalai SS; Bentley JP; Toyama H; Pajarito S; Najarian T
    Int J Eat Disord; 2020 Feb; 53(2):266-277. PubMed ID: 31721257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of human abuse potential of dasotraline compared to methylphenidate and placebo in recreational stimulant users.
    Koblan KS; Hopkins SC; Sarma K; Gallina N; Jin F; Levy-Cooperman N; Schoedel KA; Loebel A
    Drug Alcohol Depend; 2016 Feb; 159():26-34. PubMed ID: 26794682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.
    Claudino AM; de Oliveira IR; Appolinario JC; Cordás TA; Duchesne M; Sichieri R; Bacaltchuk J
    J Clin Psychiatry; 2007 Sep; 68(9):1324-32. PubMed ID: 17915969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the yale-brown obsessive compulsive scale modified for binge eating.
    Deal LS; Wirth RJ; Gasior M; Herman BK; McElroy SL
    Int J Eat Disord; 2015 Nov; 48(7):994-1004. PubMed ID: 26032442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of rimonabant in obese patients with binge eating disorder.
    Pataky Z; Gasteyger C; Ziegler O; Rissanen A; Hanotin C; Golay A
    Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):20-6. PubMed ID: 23147209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial.
    Hudson JI; McElroy SL; Raymond NC; Crow S; Keck PE; Carter WP; Mitchell JE; Strakowski SM; Pope HG; Coleman BS; Jonas JM
    Am J Psychiatry; 1998 Dec; 155(12):1756-62. PubMed ID: 9842788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
    Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W
    Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binge eating disorder revisited: what's new, what's different, what's next.
    Citrome L
    CNS Spectr; 2019 Aug; 24(S1):4-13. PubMed ID: 31196238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.
    Wilfley DE; Crow SJ; Hudson JI; Mitchell JE; Berkowitz RI; Blakesley V; Walsh BT;
    Am J Psychiatry; 2008 Jan; 165(1):51-8. PubMed ID: 18056225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study.
    Brownley KA; Von Holle A; Hamer RM; La Via M; Bulik CM
    J Psychosom Res; 2013 Jul; 75(1):36-42. PubMed ID: 23751236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder.
    McElroy SL; Guerdjikova AI; Blom TJ; Crow SJ; Memisoglu A; Silverman BL; Ehrich EW
    Int J Eat Disord; 2013 Apr; 46(3):239-45. PubMed ID: 23381803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.